Sheel Biotech Ltd Financials
Company Logo

Sheel Biotech Ltd Financial Statement

Sheel Biotech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Sheel Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual101.75
Operating Expenses Annual86.78
Operating Profit Annual15.49
Interest Annual1.77
Depreciation0.90
Net Profit Annual10.64
Tax Annual2.19

Sheel Biotech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.60
Cash Flow from Operations9.21
Cash Flow from Investing-2.25
Cash Flow from Financing-7.10
Cash Flow at the End0.46

Sheel Biotech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)14.03
PBIT Margin (%)13.21
PBT Margin (%)5.74
Net PROFIT Margin (%)9.63
Return On Networth / Equity (%)13.59
Return On Networth /Employed (%)14.72
Return On Assets (%)10.69
Total Debt / Equity (X)0.26
Asset Turnover Ratio (%)1.11

Sheel Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual7.49
Total Current Assets Annual101.09
Non Current Assets Annual12.19
Total Shareholders Funds Annual83.85
Total Assets Annual113.28

Sheel Biotech Ltd Earning Calls

No Data Availabe

FAQS on Sheel Biotech Ltd Financials

As of Oct 8, 2025, Sheel Biotech Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Sheel Biotech Ltd is with a debt-to-equity ratio of 0.21.

In FY 2024 , Sheel Biotech Ltd recorded a total revenue of approximately 101.75 Cr marking a significant milestone in the company's financial performance.

Sheel Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.1% annually, respectively..

Sheel Biotech Ltd's current PE ratio is .

Sheel Biotech Ltd's ROCE averaged 12.7% from the FY ending March 2023 to 2025, with a median of 14.3%. It peaked at 14.4% in March 2025, reflecting strong capital efficiency over the period..

Sheel Biotech Ltd's latest EBIT is Rs. 14.59 Cr, surpassing the average EBIT of Rs. 12.07 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions